HelloYoungBoy wrote: » I was in the exact same boat, it was one or the other for me. I wouldn't loose all hope in GAN yet but I do think Draftkings is definitely going to be the bigger winner here in terms of return in the long run
crushproof wrote: » Raging, had enough for either GAN or draftkings. Flip of the coin and of course my luck that GAN won.
One More Toy wrote: » Draftkings is the gift that keeps on giving, up 67% since I bought it
retalivity wrote: » I got the email from degiro yesterday: Still confused though, there are 3 listing for that ISIN, and the one in LSE is listed in pence, not euro
We would like to inform you of an upcoming corporate action. INTERNAT. CONS. AIRL. GROUP SA has announced an upcoming rights issue, for which you may find the details below: Exercising 2 rights gives you the possibility to acquire 3 new shares at a price of 0,92 EUR per share. Subscriptions are only allowed in multiples of 3 lots. New shares will be delivered under the following ISIN: ES0177542018. The internal deadline for subscribing the rights is set for the 22nd of September 2020 at 16:30 GMT. How do I participate in this corporate action? If you wish to participate, we kindly ask that you fulfill all of the following instructions on your WebTrader: You can search for the product in the “Search” tab by the name “LSE Listing - IAG subscription offer” or by the ISIN: “ES0000LSEIAG” Place a limit buy order for € 0.92 Enter the amount of shares that you wish to subscribe Note that only multiples of 3 new shares are allowed. You cannot subscribe for more than your entitlement. Please see IMPORTANT below. Select GTC. Day orders are not accepted.
Scrunch wrote: » No, Have not got any information from Degiro about how this can be done. I think the rights need to be exercised by end of next week
Pelezico wrote: » Something must be in the offing
weemcd wrote: » #DDDD on the move again today. I'm up 137% at present, but people seem to think it will go higher once IBS trial results are released before the end of the month. I just wish I bought a lot more...
Aidan Harney wrote: » Are we still thinking that 4d pharma is a solid player to add to one's team? It has done well since first mentioned on here but the expectation even then was that it could grow rapidly....... Asking for a friend. : )
Augeo wrote: » I expect 4d to be multiples of today's price over the next 18 months and quite likely sooner .......... the market cap is insanely small for their pipeline.
Augeo wrote: » https://pharmafield.co.uk/pharma_news/mhra_fast_track_nod_for_uk_pharma_companys_covid-19_study/ 4d Pharma PLC currently under 60p, was £1 prior to a placing in Feb that was at 50p, RNS yesterday regarding Phase II study in COVID-19. Company is funded for the short term after the recent placing, they are working on a treatment not a vaccine........ as folk likely know, a vaccine being developed isn't at all guaranteed. I'd put this one as low risk but potential high reward, and it'll be sooner rather then later
butrasgali wrote: » Hello,would glanbia be worth a punt at..not sure why they are dropping..
retalivity wrote: » I think the general rule of thumb is republicans=good, democrats=bad for the stock market.
Nemeses2050 wrote: » Did anyone exercised their IAG rights?
RedRochey wrote: » Does anyone have some analysis or articles about how people are usually wrong about the affect a president will have on the market? As in 2016 people were saying the market would fall if Trump got elected but it actually did fine I'm trying to show that trying to position for the US election is hard because people's predictions of who will win and what effect they will have are usually wrong
Aidan Harney wrote: » My collaboration with degiro was successful earlier today and I've lost a few quid on 4d already... It's not a sprint I know I know... Thanks for the response & gl.
Pelezico wrote: » If that collaboration with MSD is successful, 4D will boom.
Mickiemcfist wrote: » Nicely timed
Kilboor wrote: » BOOOOOM!
Kilboor wrote: » Had to buy into GameStop today, have been watching it for weeks now and I can't miss the full short squeeze. Still think it's massively undervalued for console launch season.